Current strategies in diagnosis of inherited storage pool defects

Transfusion Medicine and Hemotherapy

Volumn 37, Issue 5, 2010, Pages 248-258

  Sandrock, Kirstin ^a   Zieger, Barbara ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Platelet dysfunction; Platelet granules; SPD; Storage pool disease

Indexed keywords

TRANEXAMIC ACID;

ARTHROGRYPOSIS; BLOOD SMEAR; BLOOD TRANSFUSION; CHEDIAK HIGASHI SYNDROME; CHOLESTASIS; CLINICAL FEATURE; DRUG EFFICACY; GRAY PLATELET SYNDROME; GRISCELLI SYNDROME; KIDNEY FAILURE; OCULAR ALBINISM; PATHOPHYSIOLOGY; QUEBEC PLATELET DISORDER; REVIEW; STORAGE POOL DISEASE; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; WISKOTT ALDRICH SYNDROME;

EID: 77957843636     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320279     Document Type: Review

References (75)

1. Simon D, Kunicki T, Nugent D: Platelet function defects. Haemophilia 2008;14:1240-1249
2. Nurden P, Nurden AT: Congenital disorders associated with platelet dysfunctions. Thromb Haemost 2008;99:253-263
3. Raccuglia G: Gray platelet syndrome. A variety of qualitative platelet disorder. Am J Med 1971;51: 818-828
4. White JG: Ultrastructural studies of the gray platelet syndrome. Am J Pathol 1979;95:445-462
5. Mori K, Suzuki S, Sugai K: Electron microscopic and functional studies on platelets in gray platelet syndrome. Tohoku J Exp Med 1984;143:261-287
6. Nurden P, Jandrot-Perrus M, Combrie R, Winckler J, Arocas V, Lecut C, Pasquet JM, Kunicki TJ, Nur-den AT: Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome. Blood 2004; 104:107-114
7. Nurden AT, Nurden P: The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007;21:21-36
8. Jantunen E, Hanninen A, Naukkarinen A, Vor-nanen M, Lahtinen R: Gray platelet syndrome with splenomegaly and signs of extramedullary hemato-poiesis: a case report with review of the literature. Am J Hematol 1994;46:218-224
9. Drouin A, Favier R, Masse JM, Debili N, Schmitt A, Elbim C, Guichard J, Adam M, Gougerot-Pocidalo MA, Cramer EM: Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001;98:1382-1391
10. Nurden AT, Nurden P, Bermejo E, Combrie R, McVicar DW, Washington AV: Phenotypic heterogeneity in the Gray platelet syndrome extends to the expression of TREM family member, TLT-1. Thromb Haemost 2008;100:45-51
11. Tracy PB, Giles AR, Mann KG, Eide LL, Hoogen-doorn H, Rivard GE: Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet factor V deficiency. J Clin Invest 1984;74:1221-1228
12. Janeway CM, Rivard GE, Tracy PB, Mann KG: Factor V Quebec revisited. Blood 1996;87:3571-3578
13. Hayward CP, Cramer EM, Kane WH, Zheng S, Bouchard M, Masse JM, Rivard GE: Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules. Blood 1997;89:1243-1253
14. Hayward CP, Rivard GE, Kane WH, Drouin J, Zheng S, Moore JC, Kelton JG: An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 1996;87:4967-4978
15. Kahr WH, Zheng S, Sheth PM, Pai M, Cowie A, Bouchard M, Podor TJ, Rivard GE, Hayward CP: Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood 2001; 98:257-265
16. Diamandis M, Paterson AD, Rommens JM, Veljkovic DK, Blavignac J, Bulman DE, Waye JS, Derome F, Rivard GE, Hayward CP: Quebec platelet disorder is linked to the urokinase plasmin-ogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes. Blood 2009;113:1543-1546
17. Paterson AD, Rommens JM, Bharaj B, Blavignac J, Wong I, Diamandis M, Waye JS, Rivard GE, Hayward CP: Persons with Quebec platelet disorder have a tandem duplication of PLAU, the uroki-nase plasminogen activator gene. Blood 2010;115: 1264-1266
18. McKay H, Derome F, Haq MA, Whittaker S, Arnold E, Adam F, Heddle NM, Rivard GE, Hay-ward CP: Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood 2004; 104:159-165
19. Nezelof C, Dupart MC, Jaubert F, Eliachar E: A lethal familial syndrome associating arthrogryposis multiplex congenita, renal dysfunction, and a chole-static and pigmentary liver disease. J Pediatr 1979; 94:258-260
20. Coleman RA, Van Hove JL, Morris CR, Rhoads JM, Summar ML: Cerebral defects and nephrogen-ic diabetes insipidus with the ARC syndrome: additional findings or a new syndrome (ARCC-NDI)? Am J Med Genet 1997;72:335-338
21. Gissen P, Johnson CA, Morgan NV, Stapelbroek JM, Forshew T, Cooper WN, McKiernan PJ, Klomp LW, Morris AA, Wraith JE, McClean P, Lynch SA, Thompson RJ, Lo B, Quarrell OW, Di RM, Trembath RC, Mandel H, Wali S, Karet FE, Knisely AS, Houwen RH, Kelly DA, Maher ER: Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause ar-throgryposis-renal dysfunction-cholestasis (ARC) syndrome. Nat Genet 2004;36:400-404
22. Lo B, Li L, Gissen P, Christensen H, McKiernan PJ, Ye C, Abdelhaleem M, Hayes JA, Williams MD, Chitayat D, Kahr WH: Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis. Blood 2005;106:4159-4166
23. Gissen P, Tee L, Johnson CA, Genin E, Caliebe A, Chitayat D, Clericuzio C, Denecke J, Di RM, Fischler B, FitzPatrick D, Garcia-Cazorla A, Guyot D, Jacquemont S, Koletzko S, Leheup B, Mandel H, Sanseverino MT, Houwen RH, McKiernan PJ, Kelly DA, Maher ER: Clinical and molecular genetic features of ARC syndrome. Hum Genet 2006; 120:396-409
24. Cullinane AR, Straatman-Iwanowska A, Zaucker A, Wakabayashi Y, Bruce CK, Luo G, Rahman F, Gurakan F, Utine E, Ozkan TB, Denecke J, Vu-kovic J, Di RM, Mandel H, Cangul H, Matthews RP, Thomas SG, Rappoport JZ, Arias IM, Wol-burg H, Knisely AS, Kelly DA, Muller F, Maher ER, Gissen P: Mutations in VIPAR cause an ar-throgryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization. Nat Genet 2010;42:303-312
25. Jang JY, Kim KM, Kim GH, Yu E, Lee JJ, Park YS, Yoo HW: Clinical characteristics and VPS33B mutations in patients with ARC syndrome. J Pedi-atr Gastroenterol Nutr 2009;48:348-354
26. Eastham KM, McKiernan PJ, Milford DV, Ramani P, Wyllie J, van't Hoff W, Lynch SA, Morris AA: ARC syndrome: an expanding range of pheno-types. Arch Dis Child 2001;85:415-420
27. Jedlitschky G, Cattaneo M, Lubenow LE, Ross-kopf D, Lecchi A, Artoni A, Motta G, Niessen J, Kroemer HK, Greinacher A: Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies. Am J Pathol 2010;176:1097-1103
28. Hermansky F, Pudlak P: Albinism associated with hemorrhagic diathesis and unusual pigmented re-ticular cells in the bone marrow: report of two cases with histochemical studies. Blood 1959;14:162-169
29. Cutler DF: Introduction: lysosome-related organ-elles. Semin Cell Dev Biol 2002;13:261-262
30. Dell'Angelica EC, Mullins C, Caplan S, Bonifacino JS: Lysosome-related organelles. FASEB J 2000;14: 1265-1278
31. Summers CG, Knobloch WH, Witkop CJ Jr, King RA: Hermansky-Pudlak syndrome. Ophthalmic findings. Ophthalmology 1988;95:545-554
32. Schallreuter KU, Frenk E, Wolfe LS, Witkop CJ, Wood JM: Hermansky-Pudlak syndrome in a Swiss population. Dermatology 1993;187:248-256
33. Witkop CJ, Nunez BM, Rao GH, Gaudier F, Summers CG, Shanahan F, Harmon KR, Townsend D, Sedano HO, King RA, et al: Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R 1990;82:333-339
34. Li W, Rusiniak ME, Chintala S, Gautam R, Novak EK, Swank RT: Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related organ-elles. Bioessays 2004;26:616-628
35. Korswagen LA, Huizing M, Simsek S, Janssen JJ, Zweegman S: A novel mutation in a Turkish patient with Hermansky-Pudlak syndrome type 5. Eur J Haematol 2008;80:356-360
36. Enders A, Zieger B, Schwarz K, Yoshimi A, Speckmann C, Knoepfle EM, Kontny U, Muller C, Nurden A, Rohr J, Henschen M, Pannicke U, Niemeyer C, Nurden P, Ehl S: Lethal hemophago-cytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. Blood 2006;108:81-87
37. Huizing M, Pederson B, Hess RA, Griffin A, Helip-Wooley A, Westbroek W, Dorward H, O'Brien KJ, Golas G, Tsilou E, White JG, Gahl WA: Clinical and cellular characterisation of Hermansky-Pudlak syndrome type 6. J Med Genet 2009;46:803-810
38. Li W, Zhang Q, Oiso N, Novak EK, Gautam R, O'Brien EP, Tinsley CL, Blake DJ, Spritz RA, Copeland NG, Jenkins NA, Amato D, Roe BA, Starcevic M, Dell'Angelica EC, Elliott RW, Mishra V, Kingsmore SF, Paylor RE, Swank RT: Herman-sky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet 2003;35:84-89
39. Fallgatter AJ, Ehlis AC, Herrmann MJ, Hohoff C, Reif A, Freitag CM, Deckert J: DTNBP1 (Dysbin-din) gene variants modulate prefrontal brain function in schizophrenic patients-support for the glu-tamate hypothesis of schizophrenias. Genes Brain Behav 2010;9:489-497
40. Strohmaier J, Frank J, Wendland JR, Schumacher J, Jamra RA, Treutlein J, Nieratschker V, Breuer R, Mattheisen M, Herms S, Muhleisen TW, Maier W, Nothen MM, Cichon S, Rietschel M, Schulze TG: A reappraisal of the association between Dys-bindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry. Schizophr Res 2010;118:98-105
41. Morgan NV, Pasha S, Johnson CA, Ainsworth JR, Eady RA, Dawood B, McKeown C, Trembath RC, Wilde J, Watson SP, Maher ER: A germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8). Am J Hum Genet 2006;78:160-166
42. Sato A: Chediak and Higashi's disease: probable identity of a new leucocytal anomaly (Chediak) and congenital gigantism of peroxidase granules (Higashi). Tohoku J Exp Med 1955;61:201-210
43. Donohue WL, Bain HW: Chediak-Higashi syndrome; a lethal familial disease with anomalous inclusions in the leukocytes and constitutional stigmata: report of a case with necropsy. Pediatrics 1957;20:416-430
44. Barbosa MD, Nguyen QA, Tchernev VT, Ashley JA, Detter JC, Blaydes SM, Brandt SJ, Chotai D, Hodgman C, Solari RC, Lovett M, Kingsmore SF: Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996;382: 262-265
45. Nagle DL, Karim MA, Woolf EA, Holmgren L, Bork P, Misumi DJ, McGrail SH, Dussault BJ Jr, Perou CM, Boissy RE, Duyk GM, Spritz RA, Moore KJ: Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996;14:307-311
46. Karim MA, Suzuki K, Fukai K, Oh J, Nagle DL, Moore KJ, Barbosa E, Falik-Borenstein T, Fili-povich A, Ishida Y, Kivrikko S, Klein C, Kreuz F, Levin A, Miyajima H, Regueiro J, Russo C, Uyama E, Vierimaa O, Spritz RA: Apparent gen-otype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome. Am J Med Genet 2002;108:16-22
47. Certain S, Barrat F, Pastural E, Le DF, Goyo-Rivas J, Jabado N, Benkerrou M, Seger R, Vilmer E, Beullier G, Schwarz K, Fischer A, de Saint BG: Protein truncation test of LYST reveals heterog-enous mutations in patients with Chediak-Higashi syndrome. Blood 2000;95:979-983
48. Eapen M, DeLaat CA, Baker KS, Cairo MS, Cowan MJ, Kurtzberg J, Steward CG, Veys PA, Filipovich AH: Hematopoietic cell transplantation for Chediak-Higashi syndrome. Bone Marrow Transplant 2007;39:411-415
49. Griscelli C, Durandy A, Guy-Grand D, Daguillard F, Herzog C, Prunieras M: A syndrome associating partial albinism and immunodeficiency. Am J Med 1978;65:691-702
50. Griscelli C, Prunieras M: Pigment dilution and immunodeficiency: a new syndrome. Int J Dermatol 1978;17:788-791
51. Pastural E, Barrat FJ, Dufourcq-Lagelouse R, Certain S, Sanal O, Jabado N, Seger R, Griscelli C, Fischer A, de Saint BG: Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet 1997;16: 289-292
52. Menasche G, Ho CH, Sanal O, Feldmann J, Tezcan I, Ersoy F, Houdusse A, Fischer A, de Saint BG: Griscelli syndrome restricted to hypopigmenta-tion results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 2003; 112:450-456
53. Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S, Wulffraat N, Bianchi D, Fischer A, Le DF, de Saint BG: Mutations in RAB27A cause Griscelli syndrome associated with haemo-phagocytic syndrome. Nat Genet 2000;25:173-176
54. Barral DC, Seabra MC: The melanosome as a model to study organelle motility in mammals. Pigment Cell Res 2004;17:111-118
55. Pastural E, Ersoy F, Yalman N, Wulffraat N, Grillo E, Ozkinay F, Tezcan I, Gedikoglu G, Philippe N, Fischer A, de Saint BG: Two genes are responsible for Griscelli syndrome at the same 15q21 locus. Genomics 2000;63:299-306
56. Ivanovich J, Mallory S, Storer T, Ciske D, Hing A: 12-year-old male with Elejalde syndrome (neuro-ectodermal melanolysosomal disease). Am J Med Genet 2001;98:313-316
57. Menasche G, Fischer A, de Saint BG: Griscelli syndrome types 1 and 2. Am J Hum Genet 2002;71: 1237-1238
58. Bahadoran P, Ortonne JP, Ballotti R, de Saint-Basile G: Comment on Elejalde syndrome and relationship with Griscelli syndrome. Am J Med Genet A 2003;116A:408-409
59. Wilson SM, Yip R, Swing DA, O'Sullivan TN, Zhang Y, Novak EK, Swank RT, Russell LB, Co-peland NG, Jenkins NA: A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc Natl Acad Sci \USA 2000;97: 7933-7938
60. Biddle DA, Neto TG, Nguyen AN: Platelet storage pool deficiency of alpha and delta granules. Arch Pathol Lab Med 2001;125:1125-1126
61. Nichols KE, Crispino JD, Poncz M, White JG, Orkin SH, Maris JM, Weiss MJ: Familial dyseryth-ropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet 2000;24: 266-270
62. Del Vecchio GC, Giordani L, De SA, De MD: Dy-serythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1. Acta Haematol 2005;114:113-116
63. Phillips JD, Steensma DP, Pulsipher MA, Spangru-de GJ, Kushner JP: Congenital erythropoietic por-phyria due to a mutation in GATA1: the first transacting mutation causative for a human porphyria. Blood 2007;109:2618-2621
64. Crispino JD: GATA1 in normal and malignant he-matopoiesis. Semin Cell Dev Biol 2005;16:137-147
65. Freson K, Matthijs G, Thys C, Marien P, Hoylaerts MF, Vermylen J, Van GC: Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macro-thrombocytopenia and anemia and are associated with variable skewed X inactivation. Hum Mol Genet 2002;11:147-152
66. Mehaffey MG, Newton AL, Gandhi MJ, Crossley M, Drachman JG: X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood 2001;98:2681-2688
67. White JG: Inherited abnormalities of the platelet membrane and secretory granules. Hum Pathol 1987;18:123-139
68. Aldrich RA, Steinberg AG, Campbell DC: Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 1954;13: 133-139
69. Wiskott A: Familiärer angeborener Morbus Werl-hofii? Mschr Kinderheilk 1937;68:212-216
70. Binder V, Albert MH, Kabus M, Bertone M, Meindl A, Belohradsky BH: The genotype of the original Wiskott phenotype. N Engl J Med 2006;355:1790-1793
71. Sabri S, Foudi A, Boukour S, Franc B, Charrier S, Jandrot-Perrus M, Farndale RW, Jalil A, Blundell MP, Cramer EM, Louache F, Debili N, Thrasher AJ, Vainchenker W: Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment. Blood 2006;108:134-140
72. Ancliff PJ, Blundell MP, Cory GO, Calle Y, Worth A, Kempski H, Burns S, Jones GE, Sinclair J, Kin-non C, Hann IM, Gale RE, Linch DC, Thrasher AJ: Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neu-tropenia. Blood 2006;108:2182-2189
73. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA: A multiinstitutional survey of the Wiskott-Al-drich syndrome. J Pediatr 1994;125:876-885
74. Corash L, Shafer B, Blaese RM: Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood 1985;65:1439-1443
75. Standen GR, Lillicrap DP, Matthews N, Bloom AL: Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Q J Med 1986;59: 401-408